Mesirow Financial Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,585
Closed -$232K 537
2025
Q4
$232K Sell
2,585
-138
-5% -$13.1K ﹤0.01% 440
2025
Q3
$268K Buy
2,723
+151
+6% +$15K ﹤0.01% 477
2025
Q2
$235K Sell
2,572
-368
-13% -$35.6K ﹤0.01% 481
2025
Q1
$333K Buy
2,940
+435
+17% +$46.5K 0.01% 432
2024
Q4
$265K Sell
2,505
-2,749
-52% -$295K 0.01% 492
2024
Q3
$567K Buy
5,254
+2,563
+95% +$280K 0.01% 343
2024
Q2
$292K Sell
2,691
-25
-0.9% -$2.95K 0.01% 410
2024
Q1
$359K Buy
2,716
+726
+36% +$90.7K 0.01% 399
2023
Q4
$242K Buy
+1,990
New +$222K 0.01% 481

Other funds holding ZBH

Mesirow Financial Investment Management's ZBH Position: Q1 2026 in Review

Mesirow Financial Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 2,585 shares — an estimated $232K sold.

Mesirow Financial Investment Management first reported a position in ZBH in Q4 2023 and held it in 9 quarters. The position peaked at $567K in Q3 2024. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Mesirow Financial Investment Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 2,585 Zimmer Biomet shares in Q1 2026, an estimated $232K.
  • Mesirow Financial Investment Management first reported a position in Zimmer Biomet in Q4 2023 and held it in 9 quarters.
  • Mesirow Financial Investment Management's Zimmer Biomet position peaked at $567K in Q3 2024.
  • 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q1 2026, filed 21 Apr 2026.